Global Addisons Disease Therapeutics Market 2024-2028

Addisons Disease Therapeutics Market 2024-2028


The addisons disease therapeutics market is forecasted to grow by USD 442.4 mn during 2023-2028, accelerating at a CAGR of 6.59% during the forecast period. The report on the addisons disease therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by special drug designations, reformulation of drugs, and favourable reimbursement scenario.

Technavio's addisons disease therapeutics market is segmented as below:
  • By Therapy
  • Oral drugs
  • Parenteral drugs
  • By End-user
  • Hospitals and clinics
  • Diagnostic laboratories
  • By Geographical Landscape
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the expanding research into development of regenerative therapy as one of the prime reasons driving the addisons disease therapeutics market growth during the next few years. Also, availability of clinical guidelines and redefined pathophysiology will lead to sizable demand in the market.

The report on the addisons disease therapeutics market covers the following areas:
  • Addisons disease therapeutics market sizing
  • Addisons disease therapeutics market forecast
  • Addisons disease therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading addisons disease therapeutics market vendors that include Abbott Laboratories, Actiza Pharmaceutical Pvt. Ltd., Akorn Operating Co LLC, Amgen Inc., Amneal Pharmaceuticals Inc., Bayer AG, Bio Techne Corp., Biogen Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., BTL Biotechno Labs Pvt. Ltd., Eli Lilly and Co., GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Lupin Ltd., Merck and Co. Inc., Neurocrine Biosciences Inc., Novartis AG, Pfizer Inc., and Takeda Pharmaceutical Co. Ltd.. Also, the addisons disease therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.


1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Therapy
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Addisons Disease Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Addisons Disease Therapeutics Market 2018 - 2022 ($ million)
4.2 Therapy segment analysis 2018 - 2022
Historic Market Size - Therapy Segment 2018 - 2022 ($ million)
4.3 End-user segment analysis 2018 - 2022
Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Therapy
6.1 Market segments
Chart on Therapy - Market share 2023-2028 (%)
Data Table on Therapy - Market share 2023-2028 (%)
6.2 Comparison by Therapy
Chart on Comparison by Therapy
Data Table on Comparison by Therapy
6.3 Oral drugs - Market size and forecast 2023-2028
Chart on Oral drugs - Market size and forecast 2023-2028 ($ million)
Data Table on Oral drugs - Market size and forecast 2023-2028 ($ million)
Chart on Oral drugs - Year-over-year growth 2023-2028 (%)
Data Table on Oral drugs - Year-over-year growth 2023-2028 (%)
6.4 Parenteral drugs - Market size and forecast 2023-2028
Chart on Parenteral drugs - Market size and forecast 2023-2028 ($ million)
Data Table on Parenteral drugs - Market size and forecast 2023-2028 ($ million)
Chart on Parenteral drugs - Year-over-year growth 2023-2028 (%)
Data Table on Parenteral drugs - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Therapy
Market opportunity by Therapy ($ million)
Data Table on Market opportunity by Therapy ($ million)
7 Market Segmentation by End-user
7.1 Market segments
Chart on End-user - Market share 2023-2028 (%)
Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
7.3 Hospitals and clinics - Market size and forecast 2023-2028
Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
7.4 Diagnostic laboratories - Market size and forecast 2023-2028
Chart on Diagnostic laboratories - Market size and forecast 2023-2028 ($ million)
Data Table on Diagnostic laboratories - Market size and forecast 2023-2028 ($ million)
Chart on Diagnostic laboratories - Year-over-year growth 2023-2028 (%)
Data Table on Diagnostic laboratories - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Abbott Laboratories
Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
12.4 Actiza Pharmaceutical Pvt. Ltd.
Actiza Pharmaceutical Pvt. Ltd. - Overview
Actiza Pharmaceutical Pvt. Ltd. - Product / Service
Actiza Pharmaceutical Pvt. Ltd. - Key offerings
12.5 Akorn Operating Co LLC
Akorn Operating Co LLC - Overview
Akorn Operating Co LLC - Product / Service
Akorn Operating Co LLC - Key offerings
12.6 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
12.7 Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc. - Overview
Amneal Pharmaceuticals Inc. - Business segments
Amneal Pharmaceuticals Inc. - Key news
Amneal Pharmaceuticals Inc. - Key offerings
Amneal Pharmaceuticals Inc. - Segment focus
12.8 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
12.9 Bristol Myers Squibb Co.
Bristol Myers Squibb Co. - Overview
Bristol Myers Squibb Co. - Product / Service
Bristol Myers Squibb Co. - Key news
Bristol Myers Squibb Co. - Key offerings
12.10 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
12.11 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.12 Hikma Pharmaceuticals Plc
Hikma Pharmaceuticals Plc - Overview
Hikma Pharmaceuticals Plc - Business segments
Hikma Pharmaceuticals Plc - Key news
Hikma Pharmaceuticals Plc - Key offerings
Hikma Pharmaceuticals Plc - Segment focus
12.13 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
12.14 Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc. - Overview
Neurocrine Biosciences Inc. - Product / Service
Neurocrine Biosciences Inc. - Key offerings
12.15 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.16 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.17 Takeda Pharmaceutical Co. Ltd.
Takeda Pharmaceutical Co. Ltd. - Overview
Takeda Pharmaceutical Co. Ltd. - Product / Service
Takeda Pharmaceutical Co. Ltd. - Key news
Takeda Pharmaceutical Co. Ltd. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Addisons Disease Therapeutics Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Therapy Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Therapy - Market share 2023-2028 (%)
Exhibits33: Data Table on Therapy - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Therapy
Exhibits35: Data Table on Comparison by Therapy
Exhibits36: Chart on Oral drugs - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Oral drugs - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Oral drugs - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Oral drugs - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Parenteral drugs - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Parenteral drugs - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Parenteral drugs - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Parenteral drugs - Year-over-year growth 2023-2028 (%)
Exhibits44: Market opportunity by Therapy ($ million)
Exhibits45: Data Table on Market opportunity by Therapy ($ million)
Exhibits46: Chart on End-user - Market share 2023-2028 (%)
Exhibits47: Data Table on End-user - Market share 2023-2028 (%)
Exhibits48: Chart on Comparison by End-user
Exhibits49: Data Table on Comparison by End-user
Exhibits50: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
Exhibits51: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ million)
Exhibits52: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Exhibits54: Chart on Diagnostic laboratories - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Diagnostic laboratories - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Diagnostic laboratories - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Diagnostic laboratories - Year-over-year growth 2023-2028 (%)
Exhibits58: Market opportunity by End-user ($ million)
Exhibits59: Data Table on Market opportunity by End-user ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits62: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits101: Market opportunity By Geographical Landscape ($ million)
Exhibits102: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits103: Impact of drivers and challenges in 2023 and 2028
Exhibits104: Overview on criticality of inputs and factors of differentiation
Exhibits105: Overview on factors of disruption
Exhibits106: Impact of key risks on business
Exhibits107: Companies covered
Exhibits108: Matrix on companies position and classification
Exhibits109: Abbott Laboratories - Overview
Exhibits110: Abbott Laboratories - Business segments
Exhibits111: Abbott Laboratories - Key news
Exhibits112: Abbott Laboratories - Key offerings
Exhibits113: Abbott Laboratories - Segment focus
Exhibits114: Actiza Pharmaceutical Pvt. Ltd. - Overview
Exhibits115: Actiza Pharmaceutical Pvt. Ltd. - Product / Service
Exhibits116: Actiza Pharmaceutical Pvt. Ltd. - Key offerings
Exhibits117: Akorn Operating Co LLC - Overview
Exhibits118: Akorn Operating Co LLC - Product / Service
Exhibits119: Akorn Operating Co LLC - Key offerings
Exhibits120: Amgen Inc. - Overview
Exhibits121: Amgen Inc. - Product / Service
Exhibits122: Amgen Inc. - Key news
Exhibits123: Amgen Inc. - Key offerings
Exhibits124: Amneal Pharmaceuticals Inc. - Overview
Exhibits125: Amneal Pharmaceuticals Inc. - Business segments
Exhibits126: Amneal Pharmaceuticals Inc. - Key news
Exhibits127: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits128: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits129: Bayer AG - Overview
Exhibits130: Bayer AG - Business segments
Exhibits131: Bayer AG - Key news
Exhibits132: Bayer AG - Key offerings
Exhibits133: Bayer AG - Segment focus
Exhibits134: Bristol Myers Squibb Co. - Overview
Exhibits135: Bristol Myers Squibb Co. - Product / Service
Exhibits136: Bristol Myers Squibb Co. - Key news
Exhibits137: Bristol Myers Squibb Co. - Key offerings
Exhibits138: Eli Lilly and Co. - Overview
Exhibits139: Eli Lilly and Co. - Product / Service
Exhibits140: Eli Lilly and Co. - Key news
Exhibits141: Eli Lilly and Co. - Key offerings
Exhibits142: GlaxoSmithKline Plc - Overview
Exhibits143: GlaxoSmithKline Plc - Business segments
Exhibits144: GlaxoSmithKline Plc - Key news
Exhibits145: GlaxoSmithKline Plc - Key offerings
Exhibits146: GlaxoSmithKline Plc - Segment focus
Exhibits147: Hikma Pharmaceuticals Plc - Overview
Exhibits148: Hikma Pharmaceuticals Plc - Business segments
Exhibits149: Hikma Pharmaceuticals Plc - Key news
Exhibits150: Hikma Pharmaceuticals Plc - Key offerings
Exhibits151: Hikma Pharmaceuticals Plc - Segment focus
Exhibits152: Merck and Co. Inc. - Overview
Exhibits153: Merck and Co. Inc. - Business segments
Exhibits154: Merck and Co. Inc. - Key news
Exhibits155: Merck and Co. Inc. - Key offerings
Exhibits156: Merck and Co. Inc. - Segment focus
Exhibits157: Neurocrine Biosciences Inc. - Overview
Exhibits158: Neurocrine Biosciences Inc. - Product / Service
Exhibits159: Neurocrine Biosciences Inc. - Key offerings
Exhibits160: Novartis AG - Overview
Exhibits161: Novartis AG - Business segments
Exhibits162: Novartis AG - Key news
Exhibits163: Novartis AG - Key offerings
Exhibits164: Novartis AG - Segment focus
Exhibits165: Pfizer Inc. - Overview
Exhibits166: Pfizer Inc. - Product / Service
Exhibits167: Pfizer Inc. - Key news
Exhibits168: Pfizer Inc. - Key offerings
Exhibits169: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits170: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits171: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits172: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits173: Inclusions checklist
Exhibits174: Exclusions checklist
Exhibits175: Currency conversion rates for US$
Exhibits176: Research methodology
Exhibits177: Information sources
Exhibits178: Data validation
Exhibits179: Validation techniques employed for market sizing
Exhibits180: Data synthesis
Exhibits181: 360 degree market analysis
Exhibits182: List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings